Note dell’episodio
In this episode of BJD Talks, Sam and Meera discuss the article ‘Efficacy and safety of subcutaneous efgartigimod with prednisone in moderate-to-severe pemphigus (ADDRESS): a global, phase III, randomised controlled, double-blind trial’ by Joly et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag199 *This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*

